In the largest follow-up study of BRCA-mutated patients in the Hereditary Breast Cancer Study Group, eight new cases of pancreatic cancer were identified, out of 5089 women, in the database of BRCA1 and BRCA2 carriers, versus 3.28 expected pancreatic cancers. This evidence concerns the gene BRCA1 and pancreatic neoplasm.